Forcierte LDL-Senkung gegen sinkende Aktienkurse
The important thing is to continue to prescribe, to lower bad cholesterol, to get to them to cholesterol goals . . . and put the study in context."
Deepak Khanna, General Manager des Joint Ventures von Merck & Co. und Schering-Plough zur Vermarktung von Inegy® und Ezetrol®, in einem Interview mit CNBC zum 
größten Kursverlust der Schering-Plough-Aktie in der Geschichte des Unternehmens.[Ezetrol]
| Autor: hockeystick 2008-03-31 Link (4 Kommentare) Ihr Kommentar |
strappato 2008-03-31
The doctors who mapped out the guidelines for disorders including metabolic syndrome and high cholesterol, received far more cash than other doctors. Some experts are skeptical about the guidelines due to their low thresholds, which are capable of categorizing healthy people as being sick and in need of medication. The standard for determining whether a person has high cholesterol is set in line with Japan Atherosclerosis Society guidelines, which defines a total cholesterol count of over 220 as being high. This compares to the U.S. level of 240. Compared with this higher level, patient levels double if the figure of 220 is used.
Man sollte noch erklären, dass Merck & Co. in Deutschland unter "MSD SHARP & DOHME" läuft und Schering-Plough unter "essex Pharma". Beides Förderer der Lipid-Liga.
>> Kommentieren
strappato 2008-04-01
We're very disappointed that we didn't have the appropriate scientific discussion or debate at ACC.
ACC = Jahrestagung des American College of Cardiology.
>> Kommentieren
